Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert J Tripolt

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 26, 2023
Effects of empagliflozin in women and men with acute myocardial infarction: An analysis from the EMMY trialCaren Sourij, Faisal Aziz, Norbert J Tripolt, et al.
Cardiovascular Diabetology|July 5, 2023
Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction - a post-hoc analysis of the EMMY trialMartin Benedikt, Harald Mangge, Faisal Aziz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 18, 2022
INTERmittent FASTing in people with insulin-treated type 2 diabetes mellitus - the INTERFAST-2 study protocolAnna Obermayer, Norbert J Tripolt, Peter N Pferschy, et al.
Cardiovascular Diabetology|May 19, 2018
Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trialNorbert J Tripolt, Felix Aberer, Regina Riedl, et al.
Journal of Clinical Medicine|June 26, 2026
Inflammatory Biomarkers and Their Associations with Arrhythmic Burden Following SGLT2-I Treatment in Chronic Heart Failure-A Subanalysis of the ERASe TrialMartin Benedikt, Markus Herrmann, Faisal Aziz, et al.
Journal of Diabetes Investigation|August 26, 2018
Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid-induced hyperglycemia in patients with acute graft-versus-host disease: A randomized trialFelix Aberer, Julia K Mader, Julia Holzgruber, et al.
Cardiovascular Diabetology|September 30, 2023
Timing of SGLT2i initiation after acute myocardial infarctionDirk von Lewinski, Ewald Kolesnik, Faisal Aziz, et al.
Diabetes Care|December 12, 2022
Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled TrialAnna Obermayer, Norbert J Tripolt, Peter N Pferschy, et al.
Advances in Therapy|July 27, 2018
Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot TrialNorbert J Tripolt, Slaven Stekovic, Felix Aberer, et al.
Biomolecules|April 30, 2021
EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes MellitusAnna Obermayer, Norbert J Tripolt, Faisal Aziz, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 26, 2023
Effects of empagliflozin in women and men with acute myocardial infarction: An analysis from the EMMY trialCaren Sourij, Faisal Aziz, Norbert J Tripolt, et al.
Cardiovascular Diabetology|July 5, 2023
Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction - a post-hoc analysis of the EMMY trialMartin Benedikt, Harald Mangge, Faisal Aziz, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 18, 2022
INTERmittent FASTing in people with insulin-treated type 2 diabetes mellitus - the INTERFAST-2 study protocolAnna Obermayer, Norbert J Tripolt, Peter N Pferschy, et al.
Cardiovascular Diabetology|May 19, 2018
Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trialNorbert J Tripolt, Felix Aberer, Regina Riedl, et al.
Journal of Clinical Medicine|June 26, 2026
Inflammatory Biomarkers and Their Associations with Arrhythmic Burden Following SGLT2-I Treatment in Chronic Heart Failure-A Subanalysis of the ERASe TrialMartin Benedikt, Markus Herrmann, Faisal Aziz, et al.
Journal of Diabetes Investigation|August 26, 2018
Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid-induced hyperglycemia in patients with acute graft-versus-host disease: A randomized trialFelix Aberer, Julia K Mader, Julia Holzgruber, et al.
Cardiovascular Diabetology|September 30, 2023
Timing of SGLT2i initiation after acute myocardial infarctionDirk von Lewinski, Ewald Kolesnik, Faisal Aziz, et al.
Diabetes Care|December 12, 2022
Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled TrialAnna Obermayer, Norbert J Tripolt, Peter N Pferschy, et al.
Advances in Therapy|July 27, 2018
Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot TrialNorbert J Tripolt, Slaven Stekovic, Felix Aberer, et al.
Biomolecules|April 30, 2021
EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes MellitusAnna Obermayer, Norbert J Tripolt, Faisal Aziz, et al.
Pageof 4